You need two documents to take common drug on holiday this year
Travel and health experts have warned anyone taking weight-loss jabs to check before they go on holiday as they are banned or restricted in some countries. Mounjaro has been released for use as a weight-loss jab on the NHS in the UK and other jabs are available to buy privately.
But while weight-loss medication is legal in the UK, other countries have not approved it - meaning it could be confiscated or you could be held by the authorities if you try to import it.
Travel and health experts have explained what you need to do if you want to take your weight-loss jabs abroad this summer.
NHS GP Dr Asimah Hanif said: "There are countries where weight loss injections are restricted or banned - unlike the UK where they are more widely accepted. For example, if you were to go to the UAE, you would need pre-approval from the Ministry of Health. Or if you were to go to Japan, you would require an import certificate.
"In Singapore - you would need approval from the health services authority before travel. There are many ways you can prepare yourself according to the country you're travelling to. This will ensure a smooth journey and also allow you to continue administering your weight loss injections."
The jabs are often used for their original purpose - managing diabetes - as well as being taken for weight loss. This can mean there is an even more urgent need to keep talking them.
GP Dr Ola Otulana said: "At the moment weight loss injections such as semaglutide are widely prescribed in the UK for diabetes management and now more recently for weight management. However people may not realise that rules can differ significantly abroad as in some countries (in Asia and the Middle East), medications like semaglutide can be heavily regulated or banned entirely if they are not licensed for weight loss there.
"Even in places where they are legal, carrying injectable medications without a letter from a doctor and proof of prescription can raise issues at customs, which may lead to items being confiscated.
"If you are prescribed a weight loss injection in the UK and are planning to travel, the safest approach is to check the embassy website of your destination country in advance to confirm the rules on your medication. You should also carry your prescription, a formal letter from your GP explaining the indication and dosing, and also keep the medication in its original packaging. Some countries require you to declare any injectable or controlled medications when you arrive. Prepare and bring any necessary documentation to avoid stress while travelling / abroad and talk to your GP or pharmacist before travelling."
Travellers say they have come across a number of countries where the jabs - and other medication - can land you in trouble.
Isheeta Borkarm co-owner of Travelicious Couple, said: "Weight-loss injections like Wegovy are legal and widely used in the UK, but they're not allowed everywhere else. We've come across a few countries where bringing them in could actually get you into serious trouble.
"For example, Japan has extremely strict rules around medication import. Even certain asthma inhalers are banned, so bringing in injectable weight-loss medication, especially with a needle, without prior approval could lead to confiscation or worse.
Singapore requires prior authorisation for any injectable medication. We've heard in Thailand even prescription drugs can be flagged at customs if the paperwork isn't clear."
Five steps to take if travelling with weight loss jabs:
1. You should check embassy websites for the latest information 2. Carry your prescription and a letter from your doctor (ideally stating dosage and medical necessity). 3. Declare it at customs. 4. Avoid packing injectables in carry-ons. Use the original packaging and keep medication with their official labelling. 5. Some of these medications need refrigeration. Call hotels in advance to ensure they had a minibar fridge.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
24 minutes ago
- BBC News
Woman urges mothers to voice birthing concerns after stillborn
A mother has urged women to voice their concerns after her baby was stillborn due to "avoidable" hospital almost 39-weeks pregnant, Lucia Ford-Ferrari went to the Princess Royal Hospital in Haywards Heath in 2023 complaining of reduced foetal movements but was sent home despite her "gut feeling" that something was she returned with the same worries four days later, medics could not find her baby's Hospitals Sussex NHS Foundation Trust apologised to Lucia and her husband George for the "devastating loss" of their daughter, Freya. The trust said it had "listened, learned and made improvements" following an investigation into what happened.A five-figure settlement has also been given to the family. 'A piece of me is gone' Ms Ford-Ferrari told the BBC that she was happy the trust had acknowledged its mistakes, but it was "never going to bring Freya back"."A piece of me is gone. Parents should never lose their children," she 37-year-old said she felt she should have pressed medics to investigate more but was "afraid to challenge them".She added that when she got pregnant a second time, they did not name the baby until she was born as they were so was one of nine babies who died at hospitals run by the trust between 2021 and 2023. Ms Ford-Ferrari said she had to go through a "very difficult" 11-hour labour at the Royal Sussex County Hospital in Brighton to deliver her stillborn baby on 28 July 2023."I remember thinking it's so unfair that I'm going through this pain without having her," she weighed about 5lb (2.3kg), despite two earlier growth scans at the Princess Royal Hospital recording she was developing average weight of a baby in the UK is about 7lb 7oz (3.4kg).The trust said because of what happened to Freya, it had made "important improvements" to ultrasound protocols, education and training, and information sharing."These changes are now a part of how we work every day," it added. 'Significant errors' An internal investigation by the trust later found "significant errors" with measurements taken during ultrasound scans which, if detected, could have spotted Freya's limited trust admitted that if Ms Ford-Ferrari been referred for review by an obstetrician when she attended hospital on 21 July, Freya's death, "on the balance of probabilities", could have been Ford-Ferrari said expectant mothers should trust their instincts and always speak up to medics."If a mum-to-be decides to ask questions that save her baby, then it's worth me sharing my story - even if it's just one," she said.A "rapid" national inquiry into NHS maternity services, including those in Sussex, was announced by the government in June.
The Independent
an hour ago
- The Independent
New prostate cancer screening records improved detection rates
A new system for detecting prostate cancer has been introduced by the Royal Marsden NHS Foundation Trust, aiming to prevent unnecessary biopsies and potentially pave the way for universal screening in the UK. The current lack of universal prostate cancer screening in the UK is due to the inaccuracy of the PSA blood test, which can lead to men undergoing needless treatment. The Royal Marsden's new model has significantly improved detection rates from 27 per cent to 52 per cent, while also reducing the average time from referral to MRI scans from nine days to three. This faster pathway involves a comprehensive triage process, including physical examinations, detailed clinical history, urinary assessments, and AI-assisted imaging, to accurately identify high-risk patients and filter out low-risk cases. The system helps to avoid unnecessary investigations for men with slow-growing prostate cancer, which often does not require treatment, while ensuring those who need it receive prompt diagnosis.
Daily Mail
an hour ago
- Daily Mail
Weight loss jabs like Mounjaro linked to 'silent cancer' that is surging in under-50s, warn experts: 'We need to find out more'
Weight-loss jabs may raise the risk of kidney cancer—a 'silent killer' now striking more under-50s—even as new research suggests they could protect against other tumours. The alarm comes from the biggest study yet of patients on slimming injections such as Ozempic and Mounjaro, which tracked nearly 44,000 overweight and obese people for up to ten years. While the drugs were linked to a 17 per cent lower risk of cancer overall—with big drops in ovarian and womb tumours—researchers also uncovered a disturbing signal for kidney cancer. Patients on the jabs were about a third more likely to develop the disease than those who did not take them, with the risk highest among the under-65s and people who were overweight. Kidney cancer is one of the fastest-rising cancers in Britain and the US and is often dubbed a 'silent killer' because it rarely causes symptoms until it is advanced. Doctors warn that by the time tell-tale signs such as blood in the urine, persistent back pain or a lump under the ribs appear, it is often too late for successful treatment. Almost 14,000 Britons are diagnosed every year, with 4,700 deaths. In the US, there are around 80,000 new cases annually. If spotted early, three-quarters of patients survive at least five years – but once the cancer has spread, survival drops to just 18 per cent. Cases are also climbing sharply in younger adults. People born in 1990 are up to three times more likely to develop the disease than those born in the 1950s—a trend doctors say is partly driven by rising obesity and high blood pressure. The study, published in JAMA Oncology, compared 43,317 people prescribed the jabs with 43,315 who did not take them. In total, 891 cancers were diagnosed among jab users compared with 1,022 in non-users. But for kidney cancer there were 83 cases among users compared with 58 among non-users. Dr Hao Dai, a health data scientist at Indiana University who led the research, also expressed concern about the uptick in kidney cancer among users. 'We need to do another observational study to confirm that these drugs increase the risk,' he said. 'But from my point of view, it might be that the drugs raise the risk of some types of kidney cancer. 'We don't know, however, and need to do more research.' One theory is that the drug's common side effects, including severe nausea, vomiting, and dehydration, may trigger repeated bouts of acute kidney injury. Over time, that stress could damage kidney tissue and increase the risk of mutations that lead to cancer. Another area of concern is that the kidneys contain GLP-1 receptors. These are the same receptors Ozempic targets to regulate blood sugar and keep people full. Some scientists wonder whether constantly stimulating these receptors could cause cells in the kidneys to grow out of control, though this remains speculative and has not been proven in humans. Rapid weight loss and dramatic metabolic shifts caused by the drug might also play a role, potentially altering the body's immune response or revealing preexisting kidney issues. However Professor Paul Pharoah, a cancer specialist at Cedars-Sinai Medical Center in Los Angeles, urged caution over the findings. He said: 'While these results suggest that GLP1 receptor agonist have an effect on cancer risk the presence of an association does not mean that the association is a causal one.' Dr Stephen Lawrence, associate clinical professor at the University of Warwick, added: 'There was a slight uptick among users—two cases per 1,000 patients per year compared with 1.3 per 1,000 for non-users. 'That's about six extra cases for every 10,000 patients treated over a year. Not ideal, but still a drop in the ocean against other health benefits.' He added: 'Further research is needed before drawing any firm conclusions. The science is promising, but more research will be important to confirm these findings as more individuals begin these treatments.' At the same time, scientists found people on the jabs were significantly less likely to be diagnosed with other cancers. Rates of ovarian cancer fell by nearly half, while cases of womb cancer and certain brain tumours (meningiomas) also dropped. Overall, patients on the injections had a 17 per cent lower chance of developing cancer of any type compared with those who did not take them. The study was presented at the American Clinical Society of Oncology's annual conference in Chicago, Illinois, the largest cancer conference in the world. But experts remain cautious about over-interpreting the data, stating that the drop in cancer risk might simply be a result of weight loss itself, rather than the drugs. Slimming jabs have already been credited with cutting the risk of heart attacks, strokes and kidney failure, on top of their dramatic weight-loss effects. Experts say the latest results underline that while they may offer protection against some cancers, vigilance is still needed over the warning signs for kidney disease.
